| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c36265da75bacb64f9fa488ce3565f48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a75667a28e1d020afe2dfd0d025abb3b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 |
| filingDate |
2001-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e054ee73c044cd0a0e1ba0c595873309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00564b6a376a1e09c0b4f1ef109c40d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc307eebd7166e3bb451684279ca2f5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa43e99cb2ec0c7cfa739e6de4870041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c6be192e9bb396998d3938b68617ffe |
| publicationDate |
2002-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2431711-A1 |
| titleOfInvention |
Remedies for heart failure |
| abstract |
A method of screening a drug capable of inhibiting the expression of an OSF-2 gene or the production or function of the protein, and remedies for heart failure having these effects are provided. By monitoring the expression and variation of the above gene or the production of the protein, a useful method of diagnosing heart failure can be provided. Moreover, a transgenic animal in which the OSF-2 gene is forcedly expressed, and a method of examining changes in the gene expression or the protein production in association with the progress of the pathological conditions of heart failure or the functions of various genes or proteins by using such a transgenic animal are provided. |
| priorityDate |
2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |